Bacteriophage Production Services
Places Paragon in a Class of its Own
Despite their discovery over a century ago, bacteriophages currently present a novel paradigm to resolve a wide variety of biological problems. Interest in phage-based therapies and technologies has skyrocketed in recent years, and Paragon Bioservices is poised to deliver a diverse and extensive portfolio of contract phage service offerings including:
Research and Discovery
Paragon provides contract services that include the development and manufacturing of safe, natural , bacteriophage-based antibacterial solutions for: Food Safety, Animal Health, Biodefense, Human Therapeutics and Hospital and Industrial Sanitation.
Bacteriophages are viruses that infect only bacteria—and destroy them in the process. Moreover, the fact that these amazing organisms are capable of overcoming bacterial resistance is a major advantage over conventional antibiotics.
Paragon’s R&D team can isolate phages from any number of sources—such as plant effluents, animal carcasses, processing surfaces and environmental samples. Following isolation and characterization of its antibacterial activity, both the bacterial host cells—as well as the virus stocks—are prepared in anticipation of process development and manufacturing activities.
Our client base and target markets for these services include agencies of the Federal Government (HHS, DOD), biotechnology companies, pharmaceutical companies and global consumer product companies.
Download a brief overview of our Bacteriophage Capabilities »
Learn More »
Contact us for additional information or to request a proposal.